scispace - formally typeset
S

Shigekoto Kaihara

Researcher at University of Tokyo

Publications -  44
Citations -  341

Shigekoto Kaihara is an academic researcher from University of Tokyo. The author has contributed to research in topics: The Internet & Blood flow. The author has an hindex of 11, co-authored 44 publications receiving 340 citations.

Papers
More filters
Proceedings ArticleDOI

C-HTTP-the development of a secure, closed HTTP-based network on the Internet

TL;DR: The aim of C-HTTP is to assure institutional level security and is different in scope from other secure HTTP protocols currently proposed which are oriented toward secure end-to-end HTTP communications in which security protection is dependent on each end-user.
Journal ArticleDOI

Determination of regional pulmonary blood flow in various cardiopulmonary disorders. study and application of macroaggregated albumin (maa) labelled with i-131 (i).

TL;DR: It was demonstrated that in normal subjects supine position produced almost even distribution of blood flow to the entire lung, whereas upright position increased the flow in lower portion of the lung.
Journal ArticleDOI

Automated generation of a World Wide Web-based data entry and check program for medical applications

TL;DR: The specification of the hypertext markup language (HTML) form is extended to accommodate information necessary for data checking and software named AUTOFORM is developed, which automatically analyzes the extended HTML form and generates the corresponding ordinary HTML form, Makefile, and C source of CGI programs.
Journal ArticleDOI

Realisation of the computerised patient record; relevance and unsolved problems

TL;DR: The present situation of the CPR is reviewed, the unsolved problems in relation to security issues are discussed and the full potential of CPRs has not yet been achieved.
Journal ArticleDOI

Computerized reminders to monitor liver function to improve the use of etretinate.

TL;DR: Computerized reminders appear to improve physicians' use of a drug requiring specific prior laboratory tests according to the indications listed in the Drug Package Insert.